May, 2025-Yil
719
CLINICAL FEATURES AND MANAGEMENT APPROACHES IN PEDIATRIC
EPILEPSY
¹Xatamova Robiya
²Eshtemirov Farrux, Burxonov Temurbek
¹'²'³1st-year Residents, Department of Neurology,
Samarkand State Medical University
Affiliation
: Department of Neurology,
Samarkand State Medical University, Uzbekistan.
https://doi.org/10.5281/zenodo.15511362
Research Objective
: To investigate the clinical characteristics, seizure types, etiological
factors, and treatment responses in children with epilepsy, with a focus on optimizing
individualized therapeutic strategies.
Introduction
: Epilepsy is one of the most common chronic neurological disorders in the
pediatric population, affecting approximately 0.5–1% of children worldwide. It encompasses a
diverse group of syndromes characterized by recurrent, unprovoked seizures resulting from
abnormal electrical activity in the brain. The burden of epilepsy extends beyond seizures, affecting
cognitive, behavioral, and psychosocial development.
Pediatric epilepsy poses unique diagnostic and therapeutic challenges due to
developmental variations in seizure expression, evolving semiology, age-specific etiologies, and
potential neurodevelopmental implications. Early diagnosis, precise classification, and tailored
treatment plans are essential for achieving optimal seizure control and minimizing long-term
sequelae.
This thesis aims to provide a comprehensive overview of pediatric epilepsy based on
clinical evaluation and therapeutic outcomes in a regional cohort, thereby contributing to improved
clinical management and quality of life for affected children.
Materials and Methods
: This prospective observational study was conducted at the
Pediatric Neurology Clinic of Samarkand State Medical University over a 30-month period.
Study Population: A total of 94 children aged between 1 and 16 years diagnosed with
epilepsy were included. The diagnosis was based on the International League Against Epilepsy
(ILAE) 2017 classification criteria.
Inclusion Criteria
:
1.
Children aged 1–16 years with ≥2 unprovoked seizures >24 hours apart
2.
Normal metabolic and structural brain evaluation (where applicable)
3.
Informed parental consent
Exclusion Criteria
:
a.
Acute symptomatic seizures (e.g., febrile seizures)
b.
Epilepsy secondary to progressive neurodegenerative disorders
c.
Noncompliance with follow-up
Assessment Tools and Procedures
:
1. Detailed clinical history and seizure semiology
2. Neurological examination
3. Electroencephalogram (EEG) recordings (routine and sleep-deprived)
May, 2025-Yil
720
4. Neuroimaging (MRI) where indicated
5. Etiological workup including metabolic, infectious, and genetic testing
6. Classification of seizure type and epilepsy syndrome (ILAE 2017)
7. Treatment regimens and response monitoring over 12 months
Results
: Of the 94 children, 51 (54.3%) were boys and 43 (45.7%) were girls. The mean
age at seizure onset was 5.2 ± 3.1 years. Generalized seizures were observed in 62% of patients,
with tonic-clonic seizures being the most prevalent type. Focal seizures were recorded in 28%, and
mixed types in 10%.
Etiological Distribution
:
a.
Idiopathic epilepsy: 48%
b.
Structural (congenital malformations, perinatal hypoxic injury): 29%
c.
Genetic: 12%
d.
Metabolic/infectious: 11%
Electroencephalographic Findings
:
a.
Interictal epileptiform discharges (IEDs) were observed in 79% of patients
b.
Generalized spike-wave complexes: 58%
c.
Focal spikes: 28%
d.
Multifocal abnormalities: 13%
Imaging Results
: MRI abnormalities were found in 31% of cases, mainly cortical
dysplasia, hippocampal sclerosis, and periventricular leukomalacia.
Treatment and Outcome: All patients were started on antiepileptic drug (AED)
monotherapy or polytherapy based on seizure type and etiology. The most commonly used AEDs
were valproate, levetiracetam, carbamazepine, and oxcarbazepine.
a.
Monotherapy success (seizure-free >12 months): 58%
b.
Polytherapy required: 42%
c.
Drug-resistant epilepsy: 14% (criteria: failure of ≥2 appropriate AEDs)
Adverse Effects and Tolerability
:
a.
Sedation: 17%
b.
Weight gain: 12%
c.
Behavioral disturbances (agitation, irritability): 9%
d.
No severe idiosyncratic reactions observed
Conclusion
: Pediatric epilepsy exhibits diverse clinical and etiological profiles,
demanding individualized diagnostic and treatment strategies. The predominance of generalized
tonic-clonic seizures and idiopathic etiologies reflects typical trends in regional populations.
EEG remains a cornerstone of diagnosis, with characteristic epileptiform discharges
guiding both syndrome classification and treatment choice. Structural imaging further aids in
identifying causative lesions in focal epilepsy cases, influencing both medical and surgical
management options.
Monotherapy remains effective for seizure control in over half of pediatric patients,
reinforcing the principle of starting treatment with the most appropriate single agent. However, a
substantial subset requires combination therapy due to multifocal or refractory epilepsy patterns.
May, 2025-Yil
721
Clinical vigilance is essential in early detection of drug-resistant epilepsy, prompting
timely referral for advanced diagnostics and consideration of non-pharmacological therapies (e.g.,
ketogenic diet, vagus nerve stimulation, epilepsy surgery).
The findings underscore the necessity of a multidisciplinary approach involving
neurologists, pediatricians, psychologists, and educational specialists to support holistic care.
Regular follow-up, parental education, and psychosocial support significantly enhance
long-term outcomes.
Ultimately, early diagnosis, seizure-type specific therapy, and personalized management
plans remain the key to improving prognosis and quality of life for children living with epilepsy.
REFERENCE
S
1.
Uskov A. et al. Modern methods of therapeutic fasting as a way to overcome the
pharmacoresistance of mental pathology //Science and innovation. – 2023. – Т. 2. – №.
D12. – С. 179-185.
2.
Abdukodirova S. SPECIFIC CHARACTERISTICS AND TREATMENT OF ACUTE
OBSTRUCTIVE BRONCHITIS IN CHILDREN OF EARLY AGE //Science and
innovation. – 2023. – Т. 2. – №. D11. – С. 5-8.
3.
Tahirova J. et al. Insomnia problem causes of sleep disorder, help measures at home
//Science and innovation. – 2022. – Т. 1. – №. D8. – С. 521-525.
4.
Sultanov S. et al. Long-term salbi effects of the covid-19 pandemic on the health of existing
residents of alcohol addiction //Science and innovation. – 2023. – Т. 2. – №. D11. – С.
430-438.
5.
Madaminov M., . Breast cancer detection methods, symptoms, causes, treatment //Science
and innovation. – 2022. – Т. 1. – №. D8. – С. 530-535.
6.
Шерназаров
Самандар,
Курбаниязова
ВЕ,
Виктория
Саркисова
Владимировна.(2023). Клиническое значение микробиоты кишечника у
новорожденных с геморрагической болезнью. IQRO JURNALI, 2 (2), 867-877
[Электронный ресурс].
7.
Tahirova J., . Symptoms of hymoritis, treatment, methods of folk medicine, prevention
//Science and innovation. – 2022. – Т. 1. – №. D8. – С. 983-990.
8.
Jalalova D. et al. СОЧЕТАННАЯ СТОМАТОЛОГИЧЕСКАЯ И ГЛАЗНАЯ
ПАТОЛОГИЯ //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 91-100.
9.
Tohirova J. D. Jalalova TYPES OF HEMORRHAGIC DISEASES //CHANGES IN
NEWBOENS, THEIR EARLY DIAGNOSIS.-2022.
10.
Tahirova J. et al. Neurose causes and mechanisms of development, symptoms, treatment,
prevention //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 515-520.
11.
Kiyomov I., . IMPROVING SURGICAL TREATMENT METHODS FOR PATIENTS
WITH NASAL PATHOLOGY //Science and innovation. – 2023. – Т. 2. – №. D11. – С.
226-231.
12.
Sarkisova V. et al. CYTOKINE PROFILE IN PATIENTS WITH GRANULOMATOSIS
WITH POLYANGIITIS (WEGENER'S) //Science and innovation. – 2023. – Т. 2. – №.
D11. – С. 336-343.
May, 2025-Yil
722
13.
Sarkisova V., Lapasova Z., O. Rakhmanov INFLAMMATORY DISEASES OF THE
PELVIC WOMEN ORGANS. – 2023.
14.
Jalalova D., Raxmonov X., . РОЛЬ С–РЕАКТИВНОГО БЕЛКА В ПАТОГЕНЕЗЕ
СОСУДИСТЫХ
ЗАБОЛЕВАНИЙ
ОРГАНА
ЗРЕНИЯ
У
БОЛЬНЫХ
АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ //Science and innovation. – 2022. – Т. 1. – №. D8.
– С. 114-121.
15.
Malakhov A. et al. Modern views on the treatment and rehabilitation of patients with
dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 322-329.
16.
Jalalova D., Raxmonov X., . ЗНАЧЕНИЕ ДИСФУНКЦИИ ЭНДОТЕЛИЯ В
РАЗВИТИЕ РЕТИНОПАТИИ У БОЛЬНЫХ АГ И ПУТИ ЕГО КОРРЕКЦИИ
//Science and innovation. – 2022. – Т. 1. – №. D8. – С. 101-113.
17.
Madaminov M., .Acute tonsillitis (angina) causes, complications, diagnosis, treatment,
prevention //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 771-779.
18.
F. The problem of insomnia causes of sleep disorder, remedies at home //Science and
innovation. – 2023. – Т. 2. – №. D1. – С. 79-84.
19.
Sattarova S., FEATURES OF ELECTROPHYSIOLOGICAL METHODS FOR
GUILLAIN–BARRÉ SYNDROME //Science and innovation. – 2023. – Т. 2. – №. D10. –
С. 199-204.
20.
F. Hymoritis symptoms, treatment, methods of folk medicine, prevention //Science and
innovation. – 2023. – Т. 2. – №. D1. – С. 72-78.
21.
Zhalalova D. et al. INFORMATION POINT OF PERIPHERAL BLOOD INDEXES IN
THE DIAGNOSIS OF THE ETIOLOGY OF OPTIC NERVE DAMAGE //Science and
innovation. – 2023. – Т. 2. – №. D11. – С. 124-130.
22.
Madaminov M., . Causes, symptoms, diagnosis and treatment of kidney stones
(urolithiasis). Science and Innovation. 2022; 1.8: 760-765 [Электронный ресурс].
23.
Jalalova D., Raxmonov X., . ЗНАЧЕНИЕ ДИСФУНКЦИИ ЭНДОТЕЛИЯ В
РАЗВИТИЕ РЕТИНОПАТИИ У БОЛЬНЫХ АГ И ПУТИ ЕГО КОРРЕКЦИИ
//Science and innovation. – 2022. – Т. 1. – №. D8. – С. 101-113.
24.
Rotanov, A., . (2023). Elderly epilepsy: neurophysiological aspects of non-psychotic
mental disorders. Science and innovation, 2(D12), 192-197.
25.
Konstantinova, O., . (2023). Clinical and psychological characteristics of patients with
alcoholism with suicidal behavior. Science and innovation, 2(D11), 399-404.
26.
Qizi, T. J. I., . (2022). Treatment of myocardial infarction and first aid. Science and
innovation, 1(D3), 317-320.
27.
Xushvaktova D., . Clinical features of mental disorders in synthetic drug users //Science
and innovation. – 2023. – Т. 2. – №. D10. – С. 242-247.
28.
Solovyova Y. et al. The relevance of psychotic disorders in the acute period of a stroke
//Science and innovation. – 2023. – Т. 2. – №. D12. – С. 212-217.
29.
Solovyova Y. et al. Suicide prevention in adolescents with mental disorders //Science and
innovation. – 2023. – Т. 2. – №. D11. – С. 303-308.
